Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep loss, alcohol, and benzodiazepine effects on simulated driving and ocular drowsiness markers
ACTRN12609000289213Phase 4Completed
- Sponsor
- Austin Health
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ethanol and Placebo-COD Research Private Ltd (3 arms), sponsored by Austin Health. Primary endpoint: Ocular drowsiness measures. Started Apr 2009; status: completed.
02
Drugs
ethanolPlacebo-COD Research Private Ltd
Beyond the preview
Go deeper on ACTRN12609000289213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000289213.